BioSpace News Archive

NorthStar Medical Radioisotopes, LLC and Inhibrx, Inc. announced a collaboration to develop and produce novel radiopharmaceuticals for the treatment of cancer.

Mantra Bio today announced it has raised $9 million in a Series A-2 financing to advance the development of its lead targeted exosome therapeutics program.

Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious disease using its patented iSPERSE™ technology, today announced successful completion of a Phase 1 trial evaluating safety and pharmacokinetics of PUR3100 in healthy volunteers.

Makana™ Therapeutics, a global leader in the field of xenotransplantation, was granted an important European patent that will catalyze xenotransplantation efforts abroad, the company announced today.

Catalyst Advisors LP, an international executive recruitment and assessment firm singularly focused on life sciences, today announced that Cissy Young, PhD, will join the firm as a partner.

Aptorum Group Limited is pleased to announce the recent publication of a joint effort for assessing a rapid-turnaround low-depth unbiased metagenomics sequencing workflow on Illumina platforms.

Akero Therapeutics, Inc., a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 10:30 a.m. P.T. in San Francisco, CA.

Replimune Group, Inc. announced the grant of inducement equity awards to Chris Sarchi, the Company’s newly appointed Chief Commercial Officer.

Replimune Group, Inc. announced the appointment of Christopher Sarchi as Replimune’s Chief Commercial Officer and the appointment of Sushil Patel, Ph.D., previously Replimune’s Chief Commercial Officer, to a newly created position of Chief Strategy Officer, effective immediately.

TeraImmune, Inc. announced the extension of a Cooperative Research and Development Agreement with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.